Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccination Against Human Papillomavirus (HPV) in Women and Men After Stem Cell Transplantation

NCT06793410 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06793410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06793410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccination Against Human Papillomavirus (HPV) in Women and Men After Stem Cell Transplantation
Lead sponsor
Vastra Gotaland Region
Phase
Phase 2
Overall status
Recruiting
Start date
May 12, 2025
Completion date
October 31, 2029
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukaemia, diffuse large b cell lymphoma (dlbcl), hpv (human papillomavirus)-associated, myelodysplastic syndrome, recipients of allogeneic stem cell transplantation